Trial Profile
Statin Therapy in Acute Influenza
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary)
- Indications Influenza virus infections
- Focus Biomarker; Pharmacodynamics
- 15 Oct 2018 Status changed from recruiting to completed.
- 31 May 2018 Planned End Date changed from 1 May 2018 to 30 Aug 2018.
- 31 May 2018 Planned primary completion date changed from 1 May 2018 to 30 Aug 2018.